{"id":"https://openalex.org/W2000320049","doi":"https://doi.org/10.1161/01.res.80.2.219","title":"Functional and Biochemical Analysis of Angiotensin II\u2013Forming Pathways in the Human Heart","display_name":"Functional and Biochemical Analysis of Angiotensin II\u2013Forming Pathways in the Human Heart","publication_year":1997,"publication_date":"1997-02-01","ids":{"openalex":"https://openalex.org/W2000320049","doi":"https://doi.org/10.1161/01.res.80.2.219","mag":"2000320049","pmid":"https://pubmed.ncbi.nlm.nih.gov/9012744"},"language":"en","primary_location":{"id":"doi:10.1161/01.res.80.2.219","doi":"https://doi.org/10.1161/01.res.80.2.219","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.res.80.2.219","pdf_url":null,"source":{"id":"https://openalex.org/S10652568","display_name":"Circulation Research","issn_l":"0009-7330","issn":["0009-7330","1524-4571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044263578","display_name":"Arlene C. Wolny","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Arlene Wolny","raw_affiliation_strings":["the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113773460","display_name":"Jean\u2010Paul Clozel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Jean-Paul Clozel","raw_affiliation_strings":["the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010587302","display_name":"Josiane Rein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Josiane Rein","raw_affiliation_strings":["the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007406276","display_name":"Paul Mory","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Paul Mory","raw_affiliation_strings":["the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019974836","display_name":"Paul Robert Vogt","orcid":"https://orcid.org/0000-0001-9649-2940","observed_orcids":["https://orcid.org/0000-0001-9649-2940"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Paul Vogt","raw_affiliation_strings":["the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021636700","display_name":"Marko Turino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Marko Turino","raw_affiliation_strings":["the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060621600","display_name":"Wolfgang Kiowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Wolfgang Kiowski","raw_affiliation_strings":["the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I4210100468"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030736413","display_name":"Walter Fischli","orcid":"https://orcid.org/0000-0002-6816-834X","observed_orcids":["https://orcid.org/0000-0002-6816-834X"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Walter Fischli","raw_affiliation_strings":["the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland, and the Division of Cardiovascular Surgery and Cardiology, Universita\u00a8tsspital Zu\u00a8rich (Switzerland)","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I4210100468"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":17.8633,"has_fulltext":false,"cited_by_count":243,"citation_normalized_percentile":{"value":0.9945849,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"80","issue":"2","first_page":"219","last_page":"227"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiotensin-ii-formation","display_name":"angiotensin II formation","score":0.9620000123977661},{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.9800000190734863},{"id":"https://openalex.org/keywords/angiotensin-converting-enzyme","display_name":"angiotensin-converting enzyme","score":0.9110000133514404},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.8230000138282776},{"id":"https://openalex.org/keywords/chymase","display_name":"chymase","score":0.921999990940094},{"id":"https://openalex.org/keywords/serine-protease","display_name":"serine protease","score":0.8759999871253967},{"id":"https://openalex.org/keywords/coronary-arteries","display_name":"coronary arteries","score":0.7699999809265137},{"id":"https://openalex.org/keywords/ventricular-tissue","display_name":"ventricular tissue","score":0.8180000185966492},{"id":"https://openalex.org/keywords/renin-inhibitors","display_name":"renin inhibitors","score":0.7910000085830688},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9490000009536743},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6710000038146973},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.9860000014305115}],"concepts":[{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.7899829149246216},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.6788690090179443},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.6759110689163208},{"id":"https://openalex.org/C2780614898","wikidata":"https://www.wikidata.org/wiki/Q5118578","display_name":"Chymase","level":3,"score":0.6665574312210083},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6417580842971802},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.6372538805007935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5536167621612549},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.5505386590957642},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4647931456565857},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46369847655296326},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.44973862171173096},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4448462128639221},{"id":"https://openalex.org/C2777807008","wikidata":"https://www.wikidata.org/wiki/Q87324999","display_name":"Serine protease","level":4,"score":0.4178513288497925},{"id":"https://openalex.org/C104849204","wikidata":"https://www.wikidata.org/wiki/Q24778533","display_name":"Angiotensin receptor","level":4,"score":0.4136827886104584},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3688729405403137},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.28024959564208984},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.2716628909111023},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.25482773780822754},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10696059465408325},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.09786835312843323}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000804","descriptor_name":"Angiotensin II","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000804","descriptor_name":"Angiotensin II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009206","descriptor_name":"Myocardium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012697","descriptor_name":"Serine Endopeptidases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053818","descriptor_name":"Chymases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1161/01.res.80.2.219","doi":"https://doi.org/10.1161/01.res.80.2.219","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.res.80.2.219","pdf_url":null,"source":{"id":"https://openalex.org/S10652568","display_name":"Circulation Research","issn_l":"0009-7330","issn":["0009-7330","1524-4571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation Research","raw_type":"journal-article"},{"id":"pmid:9012744","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9012744","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation research","raw_type":"Journal Article"},{"id":"mag:2886526720","doi":null,"is_oa":false,"landing_page_url":"https://www.ahajournals.org/doi/abs/10.1161/res.80.2.219?legid=circresaha%3B80%2F2%2F219&cited-by=yes","pdf_url":null,"source":{"id":"https://openalex.org/S10652568","display_name":"Circulation Research","issn_l":"0009-7330","issn":["0009-7330","1524-4571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Circulation Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1515025709","https://openalex.org/W1600920155","https://openalex.org/W1775749144","https://openalex.org/W1821554906","https://openalex.org/W1979352901","https://openalex.org/W1990403120","https://openalex.org/W1992351338","https://openalex.org/W1995359519","https://openalex.org/W1996699971","https://openalex.org/W1998319013","https://openalex.org/W2003081992","https://openalex.org/W2012866751","https://openalex.org/W2020993948","https://openalex.org/W2042094123","https://openalex.org/W2042289156","https://openalex.org/W2043600435","https://openalex.org/W2050359833","https://openalex.org/W2052240762","https://openalex.org/W2054037372","https://openalex.org/W2067165584","https://openalex.org/W2080792649","https://openalex.org/W2083152534","https://openalex.org/W2085147947","https://openalex.org/W2087375731","https://openalex.org/W2087827647","https://openalex.org/W2092296718","https://openalex.org/W2094412628","https://openalex.org/W2134306148","https://openalex.org/W2134348382","https://openalex.org/W2137231240","https://openalex.org/W2146061766","https://openalex.org/W2154543592","https://openalex.org/W2166605712","https://openalex.org/W2168800815","https://openalex.org/W2171083892","https://openalex.org/W2275214373","https://openalex.org/W2312388685","https://openalex.org/W2320384507","https://openalex.org/W2469805673","https://openalex.org/W2585382523","https://openalex.org/W2616741091","https://openalex.org/W4238980566","https://openalex.org/W4320300920"],"related_works":["https://openalex.org/W2117011709","https://openalex.org/W2468002914","https://openalex.org/W93759390","https://openalex.org/W2401278843","https://openalex.org/W1994582473","https://openalex.org/W1970616401","https://openalex.org/W2060395474","https://openalex.org/W2055987224","https://openalex.org/W2416570960","https://openalex.org/W2128139183"],"abstract_inverted_index":{"Blockade":[0],"of":[1,7,16,85,94,106,168,179,192,234],"the":[2,14,28,86,92,99,144,177,185,198,235],"renin-angiotensin":[3,95,236],"system":[4,96],"by":[5,30,71],"inhibition":[6,118,126],"angiotensin-converting":[8],"enzyme":[9],"(ACE)":[10],"is":[11,24,33,37,56,202],"beneficial":[12],"for":[13,176],"treatment":[15,46],"hypertension":[17],"and":[18,34,67,98,156,188,220],"congestive":[19],"heart":[20,129],"failure.":[21],"However,":[22],"it":[23],"unclear":[25],"how":[26],"complete":[27,232],"blockade":[29,97,233],"ACE":[31,48,72,111,117,125,133,137],"inhibitors":[32,112,219],"if":[35],"there":[36],"continuing":[38],"angiotensin":[39,60,63],"II":[40,61,181,212,222],"(Ang":[41,65],"II)":[42],"formation":[43],"during":[44],"chronic":[45,132],"with":[47,110],"inhibitors.":[49],"Indeed":[50],"chymase,":[51],"a":[52,140,230,239],"serine":[53,172,199],"protease,":[54],"which":[55],"able":[57,227],"to":[58,77,90,143,204,228],"form":[59],"from":[62],"I":[64,147,163],"I)":[66],"cannot":[68],"be":[69,78,226],"blocked":[70],"inhibitors,":[73],"has":[74],"been":[75],"shown":[76,150],"present":[79,87],"in":[80,103,114,127,151,154,165,183,209],"human":[81,128],"heart.":[82],"The":[83],"goal":[84],"study":[88],"was":[89,174],"evaluate":[91],"extent":[93],"Ang":[100,146,162,180,189,211,221],"II-forming":[101],"pathways":[102],"cardiac":[104,210],"tissue":[105,130],"patients":[107,115],"chronically":[108],"treated":[109],"or":[113,159],"without":[116],"therapy.":[119,135,242],"Our":[120],"studies":[121,153],"indicate":[122],"an":[123,206],"incomplete":[124],"after":[131],"inhibitor":[134],"Moreover,":[136],"contributes":[138],"only":[139],"small":[141],"portion":[142],"total":[145],"conversion,":[148],"as":[149,161,217],"biochemical":[152],"ventricular":[155],"coronary":[157,169,194],"homogenates":[158],"functionally":[160],"contractions":[164,191],"isolated":[166,193],"rings":[167],"arteries.":[170,195],"A":[171],"protease":[173,200],"responsible":[175],"majority":[178],"production":[182],"both":[184],"membrane":[186],"preparation":[187],"I-induced":[190],"In":[196],"humans,":[197],"pathway":[201],"likely":[203],"play":[205],"important":[207],"role":[208],"formation.":[213],"Thus,":[214],"drugs":[215],"such":[216],"renin":[218],"receptor":[223],"blockers":[224],"might":[225],"induce":[229],"more":[231,240],"system,":[237],"providing":[238],"efficacious":[241]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}